Engineered for consistent performance, the Hplc Column Nucleodur ® C 8 Gravity, 5 μm, 250 mm, 3 mm is designed for reversed phase (RP) separations, particularly suitable for the separation of basic and other ionizable analytes. Its high density C 8 phase based on high purity NUCLEODUR ® silica gel, with endcapping to suppress unwanted polar interactions, ensures enhanced pH stability, LC/MS suitability, and superior base deactivation (BDS). This makes it an ideal choice for method development and valuable for RP applications. With a particle size of 5 μm, this analytical separation column offers a pressure stability of 600 bar and temperature stability up to 60°C. Recommended applications include but are not limited to pharmaceuticals, antidepressants, anti-infl

• Category: Separation columns for HPLC
• Pore volume: 0.9 ml/g
• Surface chemistry: Base deactivated (BDS), High density monomeric octyl (C 8 , MOS) modification
• Interactions / retention mechanism: hydrophobic (van der Waals)
• Eluent in column: Acetonitrile - Water
• Column type: HPLC column
• Pore size: 110 Å
• pH stability: 1,0-11,0
• Phase: C 8 Gravity
• Similar phases: NUCLEOSIL ® C 8 HD Xterra ® RP 8 / MS C 8 Luna ® C 8 Zorbax ® Eclipse XDB-C 8
• Particle size: 5 µm
• USP listing: L7
• Particle type: Fully porous particles (FPP)
• Endcapped: yes
• Specific surface according to BET: 340 m²/g
• Recommended application(s): In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals
• Column volume: 1.75 ml
• Temperature stability: 60 ° C
• Pressure stability: 600 bar
• Separation principle: Reversed phase (RP)
• Column shape: Analytical separation column
• L x Ø internal (column): 250 x 3 mm